MD Anderson Cancer Center
Otolaryngology (ENT)
Dr. Mark E. Zafereo, MD
|
|
Give Review
Mark Zafereo works in the field of Otolaryngology (ENT). He attended Baylor College of Medicine. Mark Zafereo is a published physician. He published 28 publications, including: 'Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.' Mark Zafereo accepts Medicare.
Publications
- Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
- Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.
- Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal Carcinoma: Quantitative image ...
- Surgical salvage of recurrent Cancer of the head and neck.
- TNF-α promoter polymorphisms and risk of recurrence in patients with squamous Cell carcinomas of the nonoropharynx.
- Evaluation and staging of squamous Cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs.
- Incidence and pattern of second primary malignancies in patients with index oropharyngeal Cancers versus index nonoropharyngeal head and neck Cancers.
- Neighborhood deprivation and clinical outcomes among head and neck Cancer patients.
- Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal Cancers.
- Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid Carcinoma in Caucasian Americans.
- Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous Cell carcinoma of the head and neck.
- p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous Cell carcinoma of the head and neck.
- Complications and functional outcomes following complex oropharyngeal reconstruction.
- FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous Cell carcinoma of the head and neck.
- Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous Cell carcinoma of the head and neck.
- The role of salvage surgery in patients with recurrent squamous Cell carcinoma of the oropharynx.
- p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous Cell carcinoma of head and neck.
- Matched-pair analysis of race or ethnicity in outcomes of head and neck Cancer patients receiving similar multidisciplinary care.
- Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous Cell carcinoma of the head and neck.
- Supraglottoplasty for laryngomalacia with obstructive sleep apnea.
- Chronic retropharyngeal abscess presenting as obstructive sleep apnea.
- Esthesioneuroblastoma: 25-year experience at a single institution.
- Squamous Cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.
- Effect of initial treatment on disease outcome for patients with submandibular gland Carcinoma.
- Sinonasal Melanoma arising from conjunctival primary acquired melanosis.
- Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous Cell carcinoma of the head and neck.
- Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous Cell carcinoma of the head and neck.
Schools
U Of Tx Med Sch At Houston
Baylor College Of Medicine
University of Texas At Houston Medical School At Houston
MD Anderson Cancer Ctr Houston
University of Texas Austin Campus
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cochlear Implant Insertion
- Diagnostic Nasal and-or Sinus Endoscopy
- Excision of Facial Bone
- View All
Conditions Treated
- Adolescent Cancer
- Basal Cell Carcinoma
- Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Education
-
University of Texas MD Anderson Cancer Center -
Baylor College of Medicine -
University of Texas Health Science Center -
University of Texas Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1699920876 | |
| NPPES Provider LastName | ZAFEREO | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 770304000 | |
| NPPES Provider State | TX | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 118.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 34.0 | |
| Percent Opioid Claims | 28.81 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699920876 |
| Last Name Of The Provider | ZAFEREO |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Clement Chow, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Stanford M. Shoss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhishek S. Prasad, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David Devorkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan W. Ridley, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles M. Stiernberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James C. Martin Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yasmeen S. Jalal, MD |
|
|
Dr. Marvin W. Lerner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacqueline F. Mostert, MD
This Doctor is OpenDoctor Recommended.
|